| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2013 ( Subtotal = $0 ) |
| | 2013 | 2011 | PHRIXUS PHARMACEUTICALS INC | 330 EAST LIBERTY | ANN ARBOR | MI | 48104 | WASHTENAW | USA | R43NS070327 | EFFECTS OF P-188 ON RESPIRATORY FUNCTION AND DIAPHRAGM DEGENERATION IN THE MDX MO | 000 | 1 | NIH | 2/27/2013 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $622,877 ) |
| | 2012 | 2012 | PHRIXUS PHARMACEUTICALS INC | 300 N 5th Ave Ste 150 | Ann Arbor | MI | 48104-1499 | WASHTENAW | USA | R43HL110464 | TREATMENT OF MUSCULAR DYSTROPHY-ASSOCIATED DILATED CARDIOMYOPATHY WITH P-188 | 000 | 1 | NIH | 6/18/2012 | $622,877 |
| | 2012 | 2010 | PHRIXUS PHARMACEUTICALS INC | 330 EAST LIBERTY | ANN ARBOR | MI | 48104 | WASHTENAW | USA | R41HL104893 | POLOXAMER 188 MECHANISM OF ACTION IN ISCHEMIC HEART FAILURE. | 000 | 1 | NIH | 8/14/2012 | $0 |
|
| Issue Date FY: 2011 ( Subtotal = $583,225 ) |
| | 2011 | 2011 | PHRIXUS PHARMACEUTICALS INC | 300 N 5th Ave Ste 150 | Ann Arbor | MI | 48104-1499 | WASHTENAW | USA | R43NS070327 | EFFECTS OF P-188 ON RESPIRATORY FUNCTION AND DIAPHRAGM DEGENERATION IN THE MDX MO | 000 | 1 | NIH | 3/22/2011 | $583,225 |
|
| Issue Date FY: 2010 ( Subtotal = $306,708 ) |
| | 2010 | 2010 | PHRIXUS PHARMACEUTICALS INC | 300 N 5th Ave Ste 150 | Ann Arbor | MI | 48104-1499 | WASHTENAW | USA | R41HL104893 | POLOXAMER 188 MECHANISM OF ACTION IN ISCHEMIC HEART FAILURE. | 000 | 1 | NIH | 8/19/2010 | $306,708 |
|
| Issue Date FY: 2009 ( Subtotal = $379,487 ) |
| | 2009 | 2009 | PHRIXUS PHARMACEUTICALS INC | 300 N 5th Ave Ste 150 | Ann Arbor | MI | 48104-1499 | WASHTENAW | USA | R43HL095177 | DEVELOPMENT OF POLOXAMER-188 FOR THE TREATMENT OF MUSCULAR DYSTROPHY ASSOCIATED H | 000 | 1 | NIH | 1/13/2009 | $379,487 |
| | 2009 | 2009 | PHRIXUS PHARMACEUTICALS INC | 300 N 5th Ave Ste 150 | Ann Arbor | MI | 48104-1499 | WASHTENAW | USA | R43HL095177 | DEVELOPMENT OF POLOXAMER-188 FOR THE TREATMENT OF MUSCULAR DYSTROPHY ASSOCIATED H | 001 | 1 | NIH | 1/16/2009 | -$379,487 |
| | 2009 | 2009 | PHRIXUS PHARMACEUTICALS INC | 300 N 5th Ave Ste 150 | Ann Arbor | MI | 48104-1499 | WASHTENAW | USA | R43HL095177 | DEVELOPMENT OF POLOXAMER-188 FOR THE TREATMENT OF MUSCULAR DYSTROPHY ASSOCIATED H | 001 | 1 | NIH | 1/16/2009 | $379,487 |
|
| Issue Date FY: 2008 ( Subtotal = $277,646 ) |
| | 2008 | 2008 | PHRIXUS PHARMACEUTICALS INC | 330 EAST LIBERTY | ANN ARBOR | MI | 48104 | WASHTENAW | USA | R43DK080551 | POLOXAMER-188 FOR THE PREVENTION OF FIBROSIS DURING PERITONEAL DIALYSIS | 000 | 1 | NIH | 1/25/2008 | $277,646 |
|
| Issue Date FY: 2007 ( Subtotal = $215,084 ) |
| | 2007 | 2007 | PHRIXUS PHARMACEUTICALS INC | 330 EAST LIBERTY | ANN ARBOR | MI | 48104 | WASHTENAW | USA | R43HL088813 | CHRONIC TREATMENT OF HEART FAILURE WITH POLOXAMER-188 | 000 | 1 | NIH | 9/28/2007 | $215,084 |
|
|
